To identify reliable markers of LRRK2 activity in human CSF.

Brief description of study

The purpose of this research study is to evaluate new tests for Parkinson's disease (PD) that may help in developing better treatments.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Parkinsons
Age: Between 30 Years - 99 Years
Gender: All

Conditions: Parkinsons
Age: Between 30 - 99 Years
Gender: Male or Female

Updated on 05 Apr 2024. Study ID: 844136

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).